CL COLGATE PALMOLIVE CO — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$90.5

Period return

+4.69 (+5.47%)

Volume

3.7M

2026-07-21O $91.1 H $91.63 L $89.75 C $90.5MA5 $92.19MA20 $92.42MA60 $89.6MA120 $89.63

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 07. 31.Highin 10 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 15.High2 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.00%
2026. 05. 05.LowHOLD3 months ago
Barclays: Equal-Weight
US analyst rating / recommendation change.
2026. 05. 05.LowBUY3 months ago
JP Morgan: Overweight
US analyst rating / recommendation change.
2026. 05. 05.LowBUY3 months ago
UBS: Buy
US analyst rating / recommendation change.
2026. 05. 05.LowBUY3 months ago
RBC Capital: Outperform
US analyst rating / recommendation change.
2026. 04. 24.LowBUY3 months ago
Morgan Stanley: Overweight
US analyst rating / recommendation change.
2026. 04. 22.MediumBUY3 months ago
Rothschild & Co: Buy
US analyst rating / recommendation change.
2026. 04. 18.LowBUY3 months ago
JP Morgan: Overweight
US analyst rating / recommendation change.
2026. 04. 15.LowHOLD3 months ago
Barclays: Equal-Weight
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $95.84 · 19 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 07. 31.	After market close (AMC)	$0.95	—	—	$5.36B	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$0.85	—	—	$4.91B	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$2.61	—	—	$15.16B	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$1.71	—	—	$10.12B	Reported

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	997,533	$78.83M	0.12%	—	New position
2	Point72 Asset Management, L.P.	Point72 Asset Management, L.P.	234,869	$18.56M	0.03%	—	New position
3	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	4,700	$400.58K	0.00%	—	New position

COLGATE PALMOLIVE CO콜게이트

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 05.	Barclays	—	Maintain	Equal-Weight → Equal-Weight	—	Barclays: Equal-Weight
2026. 05. 05.	JP Morgan	—	Maintain	Overweight → Overweight	—	JP Morgan: Overweight
2026. 05. 05.	UBS	—	Maintain	Buy → Buy	—	UBS: Buy
2026. 05. 05.	RBC Capital	—	Maintain	Outperform → Outperform	—	RBC Capital: Outperform
2026. 04. 24.	Morgan Stanley	—	Maintain	Overweight → Overweight	—	Morgan Stanley: Overweight
2026. 04. 22.	Rothschild & Co	—	Upgrade	Neutral → Buy	—	Rothschild & Co: Neutral → Buy